Drug development is costly and its success is inherently uncertain. A candidate drug failing a late clinical trail would have significant financial consequences for the company.
As the Vioxx lawsuit continues to be played out, negative headlines and cash outflows will be a long-term concern for the company. Litigation is an ongoing concern for pharmaceutical giants.